← All trials
NCT05121740
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 13, 2021
- Primary completion
- Jan 31, 2022
- Completion date
- Apr 30, 2022
- First posted
- Nov 16, 2021
- Last posted
- Nov 16, 2021
- Enrollment
- 42
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- PharmaMarLead sponsor
- Universidad Autonoma de MadridOverall official - principal investigator
- Apices Soluciones S.L.Collaborator
- Badalona Hospital Germans Trias i PujolOverall official - principal investigator
- Clinica Quirón Salud, CórdobaOverall official - principal investigator
- Hospital Universitario HM MontepríncipeOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.